Articles tagged with 'BIOTRONIK US' | BIOTRONIK

BIOTRONIK - Archive (BIOTRONIK US)

2019
March
14,
2019
| 14:11 PM Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, R...
Read more
February
25,
2019
| 14:44 PM Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and only ultrathin DES to outperform the clinical standard, Xience.1,2 Orsiro received CE marking in 2011 and has been used to treat more than o...
Read more
2018
September
14,
2018
| 19:30 PM Europe/Amsterdam
BIOTRONIK today announced the FDA approval of the PK Papyrus covered coronary stent system under Humanitarian Device Exemption for use in the emergency treatment of acute coronary perforations.1,2 PK Papyrus received CE marking in 2013. Built on B...
Read more
August
27,
2018
| 19:39 PM Europe/Amsterdam
BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. Patients experiencing card...
Read more
April
03,
2018
| 19:46 PM Europe/Amsterdam
BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States. BioEnvelope will be availab...
Read more